PharmaTimes Communications Team of the Year fully booked ahead of the closing date
Due to unprecedented demand, the prestigious PharmaTimes Communications Team of the Year 2017 competition is now fully booked.
22nd August 2017
Latest news
Novartis takes aim at drug-resistant Malaria
The company and Medicines for Malaria Venture launch trial for next-gen antimalarial compound
21st August 2017
Pfizer berates NICE over ALL drug decision
Firm believes NICE inappropriately assessed the value of the drug
21st August 2017
AstraZeneca announces new mRNA collaboration
Company will partner with Ethris in respiartory disease
21st August 2017
Marketer of the Year 2017: Driving the success of brands in the modern pharma world
Market access professionals are gearing up to battle it out for the ‘National Market Access Lead of the Year’ in the upcoming PharmaTimes Marketer of the Year competition.
20th August 2017
Just 11 days left to enter!
The prestigious PharmaTimes Marketer of the Year competition closes for entries and nominations in just 11 days. Spaces are filling up fast, so If you are thinking of entering, don't hesitate any longer - take advantage of this great opportunity and submit your entry now!
20th August 2017
US regulators wave through Pfizer’s leukaemia drug
The US Food and Drug Administration has approved Pfizer’s Besponsa, the first and only CD22-directed antibody-drug conjugate indicated to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
18th August 2017
MHRA OK's psoriasis cream switch to OTC
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved the switch of Dovonex Psoriasis Ointment from a prescription-only drug to one available in pharmacies
18th August 2017
FDA expands use of AZ/Merck’s Lynparza in the US
AstraZeneca and Merck & Co’s Lynparza will be available to a wider range of patients in the US after regulators expanded the PARP inhibitor’s list of approved uses.
18th August 2017
Gov’t streams £5m into obesity research unit
The Department of Health has announced £5 million of funding for a new obesity policy research unit at University College London, alongside plans to cut calories in some foods to reign in the rising trend of childhood obesity.
18th August 2017
Global COPD deaths up 12 percent in 15 years
The number of people dying from chronic obstructive pulmonary disease has climbed nearly 12 percent over a 15-year period, an analysis for the Global Burden of Disease Study 2015 has found.
17th August 2017
Novo’s semaglutide superior to Lilly’s Trulicity in diabetes trial
Novo Nordisk’s once-weekly diabetes drug semaglutide has beaten Eli Lilly’s once-weekly therapy dulaglutide on reducing blood sugar and weight in patients taking part in a late-stage trial.
17th August 2017
CR UK, Newcastle Uni extend alliance with Astex
Cancer Research UK and Newcastle University have extended their strategic drug discovery alliance with Astex Pharmaceuticals by three years to work on developing new cancer drugs and associated biomarkers.
17th August 2017
Just two-thirds of trainee GPs plan career in NHS general practice
Only two in three doctors who are completing their training to become GPs plan to work in NHS general practice, research by the University of Warwick has found.
17th August 2017
Health officials urge young people to get meningitis jab
Public Health England and the Royal College of Nursing are urging new university students to get vaccinated against meningitis so that they can build immunity to the disease before fresher’s week, after figures show that uptake of the jab last year was low.
16th August 2017
